Catherine C. Coombs, MD, UNC School of Medicine
Advertisement
Articles by Catherine C. Coombs, MD, UNC School of Medicine
Catherine Callaghan Coombs, MD, discusses the efficacy results of the ongoing phase 1/2 BRUIN study with pirtobrutinib in chronic lymphocytic leukemia.
Advertisement
Latest Updated Articles
Therapeutic Sequencing in Relapsed/Refractory CLLPublished: January 8th 2021 | Updated:
Allogeneic Transplantation for CLLPublished: January 8th 2021 | Updated:
Frontline CLL Treatment: Addressing Unmet NeedsPublished: January 8th 2021 | Updated:
Selecting Frontline Therapy to Treat CLLPublished: January 8th 2021 | Updated:
Frontline CLL Treatment With Fixed-Duration RegimensPublished: January 8th 2021 | Updated:
Minimal Residual Disease in CLLPublished: January 8th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5